Replies to post #163122 on Biotech Values

[jq1234]

Thanks. I actually missed termination of Hemophilia B program with Baxter from May 2012. No PR, I supposed they disclosed in filing. Then no FIX anymore, just FVIII for Hemophilia A, BAX855 and other preclinical research left.